Allogene Therapeutics, Inc. ALLO NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

2/6 Pass

SharesGrow Intrinsic Value

Allogene Therapeutics, Inc. (ALLO) has 20 known insider and institutional holders on record. The largest holder is PF Equity Holdings 2 B.V. with 22,032,040 shares. Other notable holders include TPG Group Holdings (SBS) Advisors, Inc. and TPG GP A, LLC.

Over the last 12 months, insiders have made 24 transactions in ALLO stock — 14 buys (valued at $186.28K) and 9 sells (valued at $309.65K). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ALLO Insider Ownership

Top Holder

PF Equity Holdings 2 B.V.

22,032,040 shares

Buys (12 mo)

$186.28K value

Sells (12 mo)

$309.65K value

12-Month Transaction Activity

Buy 58%

Sell 38%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Pf Equity Holdings 2 B.v.	10 Percent Owner	22,032,040	2021-09-20	100%
2	Tpg Group Holdings (sbs) Advisors, Inc.	10 Percent Owner	18,729,597	2020-08-10	85%
3	Tpg Gp A, Llc	10 Percent Owner	18,716,306	2022-01-21	85%
4	Chang David D	President and CEO	5,150,599	2026-03-18	23%
5	Bhavnagri Veer	General Counsel	556,049	2023-03-16	3%
6	Amado Rafael	EVP of R&d	541,946	2022-10-11	2%
7	Schmidt Eric Thomas	Chief Financial Officer	432,738	2023-03-24	2%
8	Moore Alison	Chief Technical Officer	432,738	2023-03-24	2%
9	Belldegrun Arie	Director	263,033	2026-02-04	1%
10	Moore Timothy L.	Chief Technical Officer	250,713	2025-02-05	1%
11	Roberts Zachary	EVP of R&d	203,307	2026-02-04	1%
12	Beneski Benjamin Machinas	SVP, Chief Technical Officer	195,338	2026-04-02	1%
13	Douglas Earl Martin	SVP, General Counsel	152,480	2026-02-04	1%
14	Parker Geoffrey M.	Chief Financial Officer	152,480	2026-02-04	1%
15	Sato Vicki L	Director	144,400	2025-06-23	1%
16	Smith Lillian	VP, Corporate Counsel	140,390	2023-04-05	1%
17	Messemer Deborah M.	Director	95,400	2025-06-23	0%
18	Humer Franz B	Director	95,400	2025-06-23	0%
19	Mayo Stephen	Director	95,400	2025-06-23	0%
20	Barrett Elizabeth A.	Director	95,400	2025-06-23	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-31	Beneski Benjamin Machinas	SVP, Chief Technical Officer	Informative Sell	2,867	$2.50	$7.17K
2026-03-16	Beneski Benjamin Machinas	SVP, Chief Technical Officer	Informative Sell	4,835	$2.47	$11.94K
2026-03-16	Chang David D	President and CEO	Informative Sell	47,763	$2.47	$117.97K
2026-03-02	Beneski Benjamin Machinas	SVP, Chief Technical Officer	Informative Sell	7,132	$2.60	$18.54K
2026-02-02	Beneski Benjamin Machinas	SVP, Chief Technical Officer	RSU Award	105,720	-	-
2026-02-02	Roberts Zachary	EVP of R&d	RSU Award	203,307	-	-
2026-02-02	Yoshiyama Annie	SVP, Finance	RSU Award	50,827	-	-
2026-02-02	Chang David D	President and CEO	RSU Award	392,586	-	-
2026-02-02	Parker Geoffrey M.	Chief Financial Officer	RSU Award	152,480	-	-
2026-02-02	Douglas Earl Martin	SVP, General Counsel	RSU Award	152,480	-	-
2026-02-02	Belldegrun Arie	Director	RSU Award	263,033	-	-
2026-01-21	Roberts Zachary	EVP of R&d	Informative Sell	26,269	$1.56	$40.98K
2025-12-18	Kazam Joshua A	Director	Option Exercise (Sell)	47,700	-	-
2025-11-17	Beneski Benjamin Machinas	SVP, Chief Technical Officer	Informative Sell	786	$1.22	$958.92
2025-10-21	Parker Geoffrey M.	Chief Financial Officer	Informative Sell	36,744	$1.26	$46.17K
2025-06-18	Mayo Stephen	Director	RSU Award	95,400	-	-
2025-06-18	Barrett Elizabeth A.	Director	RSU Award	95,400	-	-
2025-06-18	Messemer Deborah M.	Director	RSU Award	95,400	-	-
2025-06-18	Witte Owen N.	Director	RSU Award	95,400	-	-
2025-06-18	Humer Franz B	Director	RSU Award	95,400	-	-
2025-06-18	Kazam Joshua A	Director	RSU Award	94,500	-	-
2025-06-18	Sato Vicki L	Director	RSU Award	144,400	$1.29	$186.28K
2025-06-10	Messemer Deborah M.	Director	Informative Sell	36,885	$1.42	$52.38K
2025-04-21	Yoshiyama Annie	SVP, Finance	Informative Sell	9,601	$1.41	$13.54K